Cargando…
Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease
Glucocorticoid excess is a known risk factor for non-alcoholic fatty liver disease (NAFLD). Our objective was to analyse the impact of glucocorticoid replacement therapy on the development of NAFLD and NAFLD-related fibrosis and, therefore, on cardiovascular as well as hepatic morbidity in patients...
Autores principales: | Meyer, Gesine, Gruendl, Madeleine, Chifu, Irina, Hahner, Stefanie, Werner, Johanna, Weiß, Johannes, Kienitz, Tina, Quinkler, Marcus, Badenhoop, Klaus, Herrmann, Eva, Friedrich-Rust, Mireen, Bojunga, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573835/ https://www.ncbi.nlm.nih.gov/pubmed/37835036 http://dx.doi.org/10.3390/jcm12196392 |
Ejemplares similares
-
BclI polymorphism of the glucocorticoid receptor and adrenal crisis in primary adrenal insufficiency
por: Zopf, Kathrin, et al.
Publicado: (2017) -
Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
por: Frey, Kathrin R, et al.
Publicado: (2018) -
Interobserver Agreement of Thyroid Imaging Reporting and Data System (TIRADS) and Strain Elastography for the Assessment of Thyroid Nodules
por: Friedrich-Rust, Mireen, et al.
Publicado: (2013) -
European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy
por: Ekman, Bertil, et al.
Publicado: (2014) -
Non-invasive assessment of tissue sodium content in patients with primary adrenal insufficiency
por: Chifu, Irina, et al.
Publicado: (2022)